figshare
Browse
12890_2017_523_MOESM9_ESM.pptx (117.58 kB)

Additional file 9: of Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis—an interim analysis of results from a prospective, single-center, randomized, parallel-group study

Download (117.58 kB)
presentation
posted on 2017-12-13, 05:00 authored by Yosuke Tanaka, Mitsunori Hino, Akihiko Gemma
Assessment of time-course changes in %DLCO in Drug-treated patients with borderline or less severe PH. A summary of results for %DLCO. (PPTX 117 kb)

History